Quantcast

Latest Vaginal bleeding Stories

2010-05-20 07:45:00

PRINCETON, N.J., May 20 /PRNewswire/ -- Novo Nordisk Inc. announced today that Vagifem® (estradiol vaginal tablets) 10 mcg will become the only available formulation of Vagifem® in the U.S., in line with medical recommendations for women to use the lowest effective estrogen dose to treat the symptoms of atrophic vaginitis due to menopause. The company will discontinue the sale of Vagifem® 25 mcg tablets in the U.S. on July 30, 2010....

2009-12-02 08:00:00

PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem® (estradiol vaginal tablets) for the treatment of atrophic vaginitis due to menopause - a condition experienced by up to 75 percent of postmenopausal women. This approval makes Vagifem® 10 mcg the lowest local estrogen therapy (LET) dose commercially available in the U.S. It will be...

2009-11-13 14:17:00

SILVER SPRING, Md., Nov. 13 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Lysteda tablets (tranexamic acid), the first non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). Lysteda works by stabilizing a protein that helps blood to clot. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Heavy menstrual bleeding is reported each year by about 3 million U.S. women of reproductive age. Women with uterine fibroids may experience...

2009-10-01 16:58:00

WAYNE, N.J., Oct. 1 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for Mirena® (levonorgestrel-releasing intrauterine system) for the treatment of heavy menstrual bleeding in women who choose to use intrauterine contraception as their method of contraception. Mirena provides an effective, non-surgical option for the treatment of heavy menstrual bleeding and is the first...

2009-10-01 16:17:00

SILVER SPRING, Md., Oct. 1 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Mirena (levonorgestrel intrauterine system) to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. This is the first intrauterine device approved by the FDA for this additional indication. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) Mirena was approved as a contraceptive by the FDA in 2000. It is...

2009-07-27 13:36:00

COLLEGEVILLE, Pa., July 27 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced the publication in Fertility and Sterility of data from a Phase 3 clinical study that showed that the investigational compound bazedoxifene/conjugated estrogens (BZA/CE) significantly reduced the frequency and severity of hot flushes and improved measures of vaginal atrophy when compared to placebo. In this study, uterine bleeding was not statistically different from...

2009-07-13 09:00:00

COLLEGEVILLE, Pa., July 13 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced the publication of data that supported daily and twice-weekly use of PREMARIN((R)) (conjugated estrogens) Vaginal Cream 0.5 g to relieve some of the bothersome symptoms of moderate-to-severe vulvar and vaginal atrophy, including painful intercourse (dyspareunia). This study evaluated the efficacy of two low-dose regimens of conjugated estrogens (CE) cream (0.5 g daily and...

2008-10-23 09:00:10

Columbia Laboratories, Inc. (Nasdaq: CBRX) has signed an agreement with the Perinatology Research Branch (PRB) of the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) for collaboration in Columbia Laboratories' ongoing PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study of PROCHIEVE(R) 8% (progesterone gel) to reduce the risk of preterm birth in women with a short cervix at mid-pregnancy. The PRB is headed by Roberto Romero, MD. "The NICHD...

2008-09-09 00:00:07

Infertility problems, caused by polycystic ovary syndrome may be helped by acupuncture, a U.S. researcher suggests. University of Virginia Health System's Lisa Pastore reports preliminary results in a trial in which she showed acupuncture may help women with PCOS -- a disease that causes hormone imbalances that interfere with ovulation and can cause infertility. "Over the last year we have seen women who never had a regular menstrual cycle start having regular periods. We can also boast...

2008-08-19 03:00:13

Geneva, Switzerland, 19 August 2008 - PregLem SA, a Swiss biopharmaceutical company specialized in reproductive medicine, today announced the start of an international Phase III clinical trial program for PGL4001 (ulipristal) in symptomatic uterine myoma, a common benign solid tumor of the genital tract in women of reproductive age. PGL4001, an orally active, selective progesterone receptor modulator, was shown in a previous Phase II study to be well...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.